Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma
Raktažodžiai
Santrauka
apibūdinimas
Present treatments for intraocular retinoblastoma cure 99% of children but have significant toxicity. Enucleation of the eye is effective but blinds the eye and leaves a lifelong cosmetic deformity. Radiation is associated with the subsequent development of fatal cancers. Systemic (intravenous)chemotherapy is used worldwide but experience with it has shown that the majority of eyes initially treated with chemotherapy still require additional treatments, such as radiation, laser, cryotherapy or even enucleation. In addition blood transfusions, secondary infections, insertion of ports and permanent hearing loss are now well reported. Three years ago we developed this technique of Chemosurgery for significantly increasing the dose of drug to the cancer while decreasing the dose of drug administered to children. This approach has decreased the need for enucleation in advanced eyes scheduled for enucleation with minimal systemic toxicity. We now offer treatment of both eyes simultaneously (in bilateral cases) and to eyes with less advanced disease and normal vision as an alternative to toxic systemic chemotherapy. In cases of very advanced ocular disease we will be using multiple drugs infused at the same session to increase tumor kill.
Chemosurgery interventions are performed under general anesthesia. The femoral artery (artery at the groin) is punctured and a catheter (a small plastic tube)is advanced into the opthalmic artery (the artery of the eye)using fluoroscopic (X-ray) guidance. The drugs are injected directly into the opthalmic artery over a period of 30-45 min.The catheter is then removed, manual compression exerted to the femoral artery, the child is awaken and goes to recovery for 6 hours. The procedure is repeated every 3-4 weeks for a total of 2 to 6 sessions according to tumor response. Since April 2006, our center has treated by chemosurgery 60 eyes in 52 patients with advanced intra-ocular retinoblastoma for which enucleation was considered.
Datos
Paskutinį kartą patikrinta: | 11/30/2009 |
Pirmasis pateikimas: | 05/11/2009 |
Numatytas registravimas pateiktas: | 05/11/2009 |
Pirmas paskelbtas: | 05/12/2009 |
Paskutinis atnaujinimas pateiktas: | 12/15/2009 |
Paskutinis atnaujinimas paskelbtas: | 12/16/2009 |
Faktinė studijų pradžios data: | 04/30/2006 |
Numatoma pirminio užbaigimo data: | 06/30/2009 |
Numatoma studijų užbaigimo data: | 06/30/2009 |
Būklė ar liga
Intervencija / gydymas
Procedure: Intra-arterial Chemotherapy
Fazė
Tinkamumo kriterijai
Amžius, tinkami studijuoti | 1 Month Į 1 Month |
Tinkamos studijoms lytys | All |
Priima sveikus savanorius | Taip |
Kriterijai | Inclusion Criteria: - advanced retinoblastoma in one or both eyes - recurrent retinoblastoma after failure of conventional methods Exclusion Criteria: - retinoblastoma judged curable by conventional methods - patient judged unable to undergo the procedure |
Rezultatas
Pirminės rezultatų priemonės
1. tumor control [6 month]
Antrinės rezultatų priemonės
1. tumor control with vision [6 month]